AIM
BPMC
Aigen Investment Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,706
| Closed | -$328K | – | 807 |
|
|
2025
Q1 | $328K | Sell |
3,706
-779
| -17% | -$68.9K | 0.05% | 473 |
|
|
2024
Q4 | $391K | Buy |
+4,485
| New | +$391K | 0.07% | 405 |
|
|
2024
Q2 | – | Sell |
-4,624
| Closed | -$439K | – | 788 |
|
|
2024
Q1 | $439K | Buy |
+4,624
| New | +$439K | 0.1% | 315 |
|
|
2023
Q3 | – | Sell |
-8,635
| Closed | -$546K | – | 838 |
|
|
2023
Q2 | $546K | Buy |
+8,635
| New | +$546K | 0.08% | 327 |
|
|
2022
Q3 | – | Sell |
-13,284
| Closed | -$671K | – | 589 |
|
|
2022
Q2 | $671K | Buy |
13,284
+4,364
| +49% | +$220K | 0.11% | 245 |
|
|
2022
Q1 | $570K | Buy |
+8,920
| New | +$570K | 0.1% | 259 |
|
|
2021
Q3 | – | Sell |
-14,314
| Closed | -$1.26M | – | 482 |
|
|
2021
Q2 | $1.26M | Buy |
+14,314
| New | +$1.26M | 0.22% | 128 |
|
|
2020
Q2 | – | Sell |
-4,549
| Closed | -$266K | – | 853 |
|
|
2020
Q1 | $266K | Buy |
4,549
+4,177
| +1,123% | +$244K | 0.04% | 627 |
|
|
2019
Q4 | $30K | Buy |
+372
| New | +$30K | 0.01% | 871 |
|